|
|
|
Volumn 26 Spec No 2, Issue , 2002, Pages
|
|
Consensus conference. Treatment of hepatitis C.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMANTADINE;
ANTIVIRUS AGENT;
INTERFERON;
RIBAVIRIN;
ADDICTION;
ADULT;
AGED;
ALCOHOLISM;
BODY WEIGHT;
CHILD;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
GENETICS;
GENOTYPE;
GRAFT REJECTION;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MALE;
MENTAL DISEASE;
MIDDLE AGED;
MONITORING;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
RECURRENT DISEASE;
RISK FACTOR;
TIME;
ADULT;
AGED;
ALCOHOLISM;
AMANTADINE;
ANTIVIRAL AGENTS;
BODY WEIGHT;
CHILD;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GENOTYPE;
GRAFT REJECTION;
HEPACIVIRUS;
HEPATITIS C;
HEPATITIS C, CHRONIC;
HIV INFECTIONS;
HUMANS;
INTERFERONS;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
MALE;
MENTAL DISORDERS;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
QUALITY OF LIFE;
RECURRENCE;
RIBAVIRIN;
RISK FACTORS;
SUBSTANCE-RELATED DISORDERS;
TIME FACTORS;
|
|
EID: 0344888710
PISSN: 03998320
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (73)
|
|
References (0)
|